Neuromyelitis Optica (Devic's Syndrome) Pipeline Review, H2 2020 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Neuromyelitis Optica - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Neuromyelitis Optica (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the de

Full Story →